An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions

Background: The aim of this thesis was to develop an evidence-based approach to the post-marketing withdrawal of medicinal products when harms are attributed to their use. Methods: Electronic and non-electronic searches were conducte...

Popoln opis

Bibliografske podrobnosti
Glavni avtor:	Onakpoya, I
Drugi avtorji:	Heneghan, C
Format:	Thesis
Jezik:	English
Izdano:	2017
Teme:	Adverse reactions Drug withdrawal

Podobne knjige/članki

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
od: Stefania Chiappini, et al.
Izdano: (2020-02-01)

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
od: Onakpoya, I, et al.
Izdano: (2016)

The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
od: Łukasz Dobrek
Izdano: (2022-08-01)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
od: Onakpoya, IJ, et al.
Izdano: (2016)

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
od: Igho J. Onakpoya, et al.
Izdano: (2019-03-01)

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
od: Onakpoya, I, et al.
Izdano: (2017)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
od: Onakpoya, I, et al.
Izdano: (2016)

Evaluating drug withdrawal syndrome risks through food and drug administration adverse event reporting system: a comprehensive disproportionality analysis
od: Zheng Zhang, et al.
Izdano: (2024-07-01)

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
od: Onakpoya, I, et al.
Izdano: (2017)

EVALUATIONS OF ADVERSE DRUGS REACTIONS IN RUSSIA IN 2013
od: V. A. Merkulov, et al.
Izdano: (2022-05-01)

Anti epileptic drug usage and withdrawal in elderly persons with epilepsy
od: Jacob Nisha, et al.
Izdano: (2007-01-01)

Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs
od: James D. Noyes, et al.
Izdano: (2021-08-01)

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
od: Daniele Sartori, et al.
Izdano: (2020-08-01)

Adverse childhood experiences: impacts on adult mental health and social withdrawal
od: Manabu Wakuta, et al.
Izdano: (2023-10-01)

Adverse Drug Reaction Related Post Detecting Using Sentiment Feature
od: Jingfang LIU, et al.
Izdano: (2018-06-01)

Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports
od: Ruoqi Liu, et al.
Izdano: (2019-12-01)

Importance of hypersensitivity in adverse reactions to drugs in the elderly
od: Maria Teresa Ventura, et al.
Izdano: (2018-04-01)

Profile of adverse drug reaction reports in South Africa: An analysis of VigiBase® for the year 2017
od: H Steyn
Izdano: (2023-06-01)

Adverse reactions by antibiotics and non-steroidal anti-inflammatory drugs
od: Karen Orellana, et al.
Izdano: (2022-03-01)

Descriptive analysis of adverse drug reaction reports in children and adolescents from Germany: frequently reported reactions and suspected drugs
od: Diana Dubrall, et al.
Izdano: (2021-10-01)

ANALYSIS OF REPORTS ON ADVERSE REACTIONS AND POOR EFFICACY OF MEDICINES IN LVIV REGION FOR THE PERIOD OF 2018-2020
od: Nataliya Stepanyuk, et al.
Izdano: (2021-12-01)

Analysis and study of the mechanism of narcotic addiction and withdrawal
od: Yan Wang, et al.
Izdano: (2024-03-01)

Unusual and interesting adverse cutaneous drug reactions
od: Vaishali Masatkar, et al.
Izdano: (2018-01-01)

Adverse systemic reaction to benznidazole
od: María Verónica Pacheco Coronel, et al.

Importance of adverse drug reaction reporting in dental practice
od: Dorota Ochyra, et al.
Izdano: (2018-09-01)

Treatment of adverse drug reactions in a dermatology department
od: Ganeva Maria, et al.
Izdano: (2011-02-01)

Rational Organisation of Adverse Drug Reaction Monitoring
od: L. V. Shukil, et al.
Izdano: (2022-10-01)

Adverse events associated with herbal medicine products reported in the Korea Adverse Event Reporting System from 2012 to 2021
od: Yujin Choi, et al.
Izdano: (2024-10-01)

Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study
od: Kishor A Bansod, et al.
Izdano: (2020-01-01)

Reversible Neurological Adverse Reaction to Apixaban
od: Eduardo Rodrigues Cernadas, et al.
Izdano: (2021-04-01)

Differences between paediatric and adult suspected neuropsychiatric adverse drug reactions of Melatonin reported to the European Medicines Agency
od: Dimitar Vaskov Bakalov, et al.
Izdano: (2021-01-01)

Risk factors for adverse drug reactions associated with clopidogrel therapy
od: Mugosa Snezana, et al.
Izdano: (2022-04-01)

Adverse drug reactions
od: AA Moghadam Nia
Izdano: (1999-01-01)

PHARMACOEPIDEMIOLOGICAL STUDIES OF ADVERSE REACTIONS OF DEVELOPED DRUGS
od: E. J. Kolesnikova
Izdano: (2022-06-01)

An evaluation of trigger tool method for adverse drug reaction monitoring at a tertiary care teaching hospital
od: Urmila Menat, et al.
Izdano: (2021-01-01)

Role of hospital pharmacists in reporting adverse drug reactions – A review
od: Sharmila P Nirojini, et al.
Izdano: (2012-01-01)

Adverse drug reaction prediction using voting ensemble training approach
od: Milad Besharatifard, et al.
Izdano: (2024-01-01)

Sex differences in pharmacokinetics predict adverse drug reactions in women
od: Irving Zucker, et al.
Izdano: (2020-06-01)